Основные атрибуты  химическое свойство Информация о безопасности химические свойства, назначение, производство поставщик Обзор
Цефтобипрол структурированное изображение

Цефтобипрол

  • английское имяCeftobiprole
  • CAS №209467-52-7
  • CBNumberCB61509106
  • ФормулаC20H22N8O6S2
  • мольный вес534.57
  • номер MDLMFCD09954116
  • файл Mol209467-52-7.mol
химическое свойство
плотность 2.00±0.1 g/cm3(Predicted)
температура хранения Store at -20°C,unstable in solution, ready to use.
растворимость DMSO : 5 mg/mL (9.35 mM)
форма Solid
пка 2.46±0.50(Predicted)
цвет Light yellow to yellow
FDA UNII 5T97333YZK
UNSPSC Code 12352200
NACRES NA.25

рисовальное письмо(GHS)

  • сигнальный язык

    опасность

Цефтобипрол химические свойства, назначение, производство

Использование

Broad spectrum antibiotic.

Антимикробная активность

The most important property distinguishing it from older cephalosporins is activity against methicillin-resistant staphylococci, a property conferred by a high affinity for penicillinbinding protein 2′ (2a). MICs for methicillin-resistant strains are nevertheless somewhat higher than those seen with fully susceptible strains. A similar situation exists with coagulasenegative staphylococci and with Str. pneumoniae, for which strains with reduced susceptibility to penicillin are less susceptible than fully resistant strains, while remaining within therapeutically achievable levels.
Otherwise activity approximates to that of cephalosporins of group 4 . Activity against Ps. aeruginosa is modest and much reduced against ceftazidime-resistant strains.

Приобретенная устойчивость

It is hydrolyzed by extended spectrum β-lactamases of enterobacteria , which are therefore resistant. The prospects for the emergence of resistance during extensive clinical use are presently unclear, though increased resistance in Staph. aureus appears to be difficult to induce under laboratory conditions.

Фармакокине?тика

Cmax 500 mg (667 mg prodrug): c. 35 mg/L end infusion
intravenous (30-min infusion)
Plasma half-life: c. 3 h
Volume of distribution: 18.4 L
Plasma protein binding: 16%
The prodrug is rapidly hydrolyzed in plasma to release the active form together with diacetyl (2,3-butanediol) and CO2. Distribution approximates to the extracellular fluid volume in adults. There is no accumulation on repeat dosing in subjects with normal renal function.
It is chiefly excreted in urine by glomerular filtration. A urinary concentration exceeding 1 g/L is achieved within the first 2 h of a 500 mg (active drug equivalent) dose and 80–90% of active drug can be recovered within 24 h.

Клиническое использование

Ceftobiprole can be used as Broad spectrum antibiotic and in complicated infections of skin and skin structures.

Побочные эффекты

Limited studies have so far revealed no unexpected side effects. Nausea, vomiting and altered taste sensation appear to be the most common.

Цефтобипрол поставщик

поставщик телефон страна номенклатура продукции благоприятные условия
+86-13131129325 China 5887 58
+86-0371-86658258
+8613203830695
China 29871 58
+1-631-485-4226 United States 19553 58
+86-023-6139-8061
+86-86-13650506873
China 39894 58
8485655694 United States 63687 58
+8618523575427 China 49732 58
United States 24072 58
United States 38631 58
+8618327326525 China 8467 58
+86-852-30606658 China 43340 58